...
首页> 外文期刊>Frontiers in Immunology >Macrophages at the Fork in the Road to Health or Disease
【24h】

Macrophages at the Fork in the Road to Health or Disease

机译:通往健康或疾病之路的叉子处的巨噬细胞

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Macrophages are the epicenter of all immune systems ( 1 ). The first and the most abundant leukocyte observed ( 2 ), macrophage have long been relegated to the role of “servants” of T or B cells/adaptive immunity. This view is now known to be backward. Macrophages necessarily initiate and direct virtually all immune responses from simple multicellular animals to humans.There is good news and bad news in the newly recognized importance of macrophages/innate immunity. The well-known “double-edged sword” nature of the immune system can largely be attributed to macrophages’ unique ability to make polar-opposite repair/heal (M2) or kill/inhibit (M1) type responses ( 3 ).In health, M2-type macrophages maintain homeostasis by helping repair and replace lost or effete cells. Ever-present in tissues, macrophages are also the primary host defense against pathogens (or altered self cells) because their unique physiology allows them to rapidly switch from their M2/heal mode to an M1/inhibit mode: both powerful responses; both potentially dangerous.In disease, over expression of M2/heal macrophages contributes to chronic infections, fibrosis, allergy, and cancer ( 3 ). Conversely, M1/inhibit-dominant activity plays a major role in atherosclerosis, autoimmunity, and other chronic inflammatory conditions.Of fundamental importance is that both the routine M2/heal and the induced M1/inhibit macrophage functions occur in all animals whether they have T cells or not. Furthermore, M1 and M2 macrophage responses play necessary roles in causing T cells to make Th1 or Th2-type responses if pathogens or altered self are present ( 4 ). Hence, the renaming of macrophage responses M1 and M2.This new knowledge about the central role of macrophages in immune systems brings great promise for increasing health/decreasing disease. In this regard, the ability of macrophages to exhibit the polar-opposite M2/heal and M1/kill functions result, in part, from their unique ability to metabolize one amino acid – arginine – to either growth-promoting ornithine or growth-inhibiting nitric oxide (NO) ( 5 ). Hence, the title of this Topic, “M1 and M2 Macrophages: The Arginine Fork in the Road to Health and Disease.” We hope that the articles assembled here help illuminate the basic functions of macrophages referred to as SHIP [sample, heal, inhibit, and present (antigen)]. Such knowledge is critical for developing the means to modulate the direct M2/heal or M1/inhibit responses of macrophages, or their indirect abilities to initiate and direct T and B cell responses. One can properly say macrophages are the “chicken and the egg” of immunity ( 1 ). Origin of M1/Inhibit and M2/Heal Macrophages and the Scope of the Topic As an introduction to M1 and M2 macrophages, a chronology of results (and publications) that led to their discovery is summarized below: Macrophages have the unique ability to produce a growth-inhibiting molecule (NO) or a growth-promoting molecule (ornithine), through the enzymatic conversion of l -arginine in different ways ( 6 – 8 ). Macrophages in normal tissues, healing wounds, or in growing tumors metabolize arginine primarily to ornithine via arginase (later to be named M2-type). Macrophages can switch to producing NO via iNOS (to be named M1-type) that is necessary to kill cancer or many pathogens. Arginine is the source of both ornithine and NO ( 9 – 12 ). Macrophages were specifically renamed M1 and M2 to highlight that innate immunity controls adaptive immunity. M1 (NO) or M2 (ornithine)-type macrophage responses are T cell independent and they stimulate Th1-type and CTL responses, or Th2-type responses, respectively ( 1 , 3 – 5 ). Thus, M1/M2 represents a sea change in our understanding of how immune responses occur. These studies have stimulated thousands of publications that have enhanced our knowledge of the importance of M1/inhibit and M2/heal functions, and other cytokines and factors that accompany these responses ( 1 ). Here, we have assembled papers by contributors that focus on basic aspects of macrophage biology, their roles in various diseases, and how they are regulated. Macrophages evolved long before other immune cell types and are the foundation of all animal immunity ( 13 ). Therefore, we begin with a series of “introductory” articles where readers can find basic information about macrophage biology and functions. These articles also trace the evolutionary origins of macrophages to aid in understanding their central role in immune systems. Next, articles detail the roles of macrophages in protection against (or causation of) various diseases including wounds, cancer, infections, atherosclerosis, obesity, hypertension, and other conditions. Finally, we look to the future with several articles detailing how macrophage M1/inhibit and M2/heal functions might be modulated for therapeutic benefits. We hope that the articles enhance your knowledge of this singularly multitalented and remarkable leukocyte. Introduct
机译:巨噬细胞是所有免疫系统的中心(1)。巨噬细胞是观察到的第一个也是最丰富的白细胞(2),长期以来一直被归类为T或B细胞的“仆人” /适应性免疫。现在已知该视图是后退的。巨噬细胞实际上必然引发并引导所有简单的多细胞动物对人类的免疫反应。新近认识到的巨噬细胞/先天免疫的重要性有好有坏。免疫系统的众所周知的“双刃剑”性质在很大程度上可归因于巨噬细胞做出极性相反的修复/治愈(M2)或杀死/抑制(M1)类型反应的独特能力(3)。 ,M2型巨噬细胞通过帮助修复和替换丢失或脱落的细胞来维持体内平衡。巨噬细胞经常存在于组织中,也是抵抗病原体(或自身细胞改变)的主要宿主防御,因为它们独特的生理学特性使它们能够迅速从M2 / Heal模式转变为M1 / Inhibit模式。在疾病中,M2 /治愈的巨噬细胞过度表达会导致慢性感染,纤维化,变态反应和癌症(3)。相反地​​,M1 /抑制主导的活性在动脉粥样硬化,自身免疫和其他慢性炎性疾病中起主要作用。最重要的是,常规的M2 /治愈和诱导的M1 /抑制巨噬细胞功能均在所有动物中发生,无论它们是否具有T细胞与否。此外,如果存在病原体或自身改变,M1和M2巨噬细胞反应在引起T细胞做出Th1或Th2型反应中起必要的作用(4)。因此,巨噬细胞应答M1和M2的重命名。有关巨噬细胞在免疫系统中的核心作用的新知识为增加健康/减少疾病提供了广阔前景。在这方面,巨噬细胞表现出与M2 / heal和M1 / kill功能相反的能力,部分是由于它们具有独特的代谢一种氨基酸精氨酸的能力,从而可以促进鸟氨酸或抑制硝酸的生长。氧化物(NO)(5)。因此,该主题的标题为“ M1和M2巨噬细胞:健康和疾病之路中的精氨酸叉”。我们希望这里组装的文章有助于阐明被称为SHIP的巨噬细胞的基本功能[样本,修复,抑制和呈递(抗原)]。这些知识对于开发调节巨噬细胞直接M2 / heal或M1 / inhibition的手段,或它们间接引发和指导T和B细胞反应的能力至关重要。可以恰当地说巨噬细胞是免疫力的“鸡和蛋”(1)。 M1 /抑制巨噬细胞和M2 /治愈巨噬细胞的起源以及主题范围作为M1和M2巨噬细胞的简介,总结了导致它们被发现的结果(和出版物)的时间顺序:巨噬细胞具有产生巨噬细胞的独特能力。抑制生长的分子(NO)或促进生长的分子(鸟氨酸),是通过1-精氨酸以不同方式进行酶促转化的方法(6-8)。正常组织,愈合伤口或生长中的肿瘤中的巨噬细胞主要通过精氨酸酶将精氨酸代谢为鸟氨酸(后来称为M2型)。巨噬细胞可以通过杀灭癌症或许多病原体所必需的iNOS(称为M1型)转变为产生NO。精氨酸是鸟氨酸和一氧化氮的来源(9 – 12)。巨噬细胞被特别重命名为M1和M2,以强调先天免疫控制适应性免疫。 M1(NO)或M2(鸟氨酸)型巨噬细胞反应与T细胞无关,它们分别刺激Th1型和CTL反应或Th2型反应(1、3-5)。因此,在我们对免疫反应如何发生的理解中,M1 / M2代表了一场巨变。这些研究激发了成千上万的出版物,这些出版物增强了我们对M1 /抑制和M2 /修复功能以及伴随这些反应的其他细胞因子和因子的重要性的认识(1)。在这里,我们收集了一些贡献者的论文,这些论文的重点是巨噬细胞生物学的基本方面,它们在各种疾病中的作用以及如何对其进行调控。巨噬细胞比其他免疫细胞类型早进化,并且是所有动物免疫的基础(13)。因此,我们从一系列“入门”文章开始,读者可以找到有关巨噬细胞生物学和功能的基本信息。这些文章还追踪了巨噬细胞的进化起源,以帮助了解它们在免疫系统中的核心作用。接下来,文章详细介绍了巨噬细胞在预防(或引起)各种疾病(包括伤口,癌症,感染,动脉粥样硬化,肥胖症,高血压和其他疾病)中的作用。最后,我们着眼于未来,撰写了几篇文章,详细介绍了如何调节巨噬细胞M1 /抑制和M2 /治愈功能以获得治疗益处。我们希望这些文章能增强您对这种多才多艺的杰出白细胞的了解。简介

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号